ARID2 and hepatocellular carcinoma: Previous findings have highlighted that ARID2 restricts the metastatic spread of HCC cells and hinders the epithelial–mesenchymal transition (EMT) by recruiting DNMT1 to the SNAIL promoter, leading to DNA methylation at the SNAIL promoter CpG island.